While other studies showed borderline significant [ 24 ] or non-significant difference [ 26 ] in the same, we believe this change is due to the addition of the more recent AGENT-IDE trial, the largest RCT comparing DCBs with UCBs in ISR to date with 600 participants [ 13 ] , into our study, thereby increasing the sample size and the power of the study.
← all excerpts
Drug-coated balloons for the treatment of in-stent restenosis: an updated systematic review and meta-analysis of randomized controlled trials.
1
—
—